[Clinical studies on cefoperazone in renal transplantation].
Two grams of Cefoperazone was intravenously administered twice a day for 5 days by drip infusion to 10 donors and 9 recipients after renal transplantation. The concentration of cefoperazone in the blood after administration in both donors and recipients did not show any accumulation tendency. The urinary recovery rate of cefoperazone for 24 hours in donors was 8.8% and that in recipients was 8.1%. There was no change in the renal function in donors after administration of cefoperazone. No change was observed in blood examination, BUN or creatinine, but S-GOT and S-GPT showed a temporary increase in 1 donor and 1 recipient. It is considered that Cefoperazone is a very useful drug for prophylactic chemotherapy after renal transplantation.
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy / Q000517:prevention & control*; D002438:Cefoperazone / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D011292:Premedication; D000637:Transaminases / Q000097:blood
D002438:Cefoperazone; D003404:Creatinine; D000637:Transaminases